MABION S.A.
Mabion S.A. is the first Polish biotechnology company and the only one in the country that has the innovation among its achievements. It was established in March 2007. On the basis of the Company’s creation laid the idea of initiating activities in the area of the economy founded on knowledge and technology. Mabion is based on the concept of combination of the latest achievements in science, research, technological and analytical projects management and implementation of the innova... tive management involving integration of science, technological and managerial knowledge.The core business is the development and implementation of the latest generation of biotech drugs based on monoclonal antibody technology.This therapeutic class is today a foundation to combat the most serious diseases thanks to two unique features - the specificity and safety.These drugs have the ability to recognize a cancer causing factor and to interact selectively only with it. This feature fits in with the concept of targeted therapies, in line with the global trend of personalized medicine.Another benefit to the patient is an extremely low toxicity of the therapy. It is obtained through a proper engineering of the drug’s structure, resembling the molecule of a patient's organism. As a result, the immune system treats the antibody protein as its own.
MABION S.A.
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2007-01-01
Address:
Konstantynów, Lodzkie, Poland
Country:
Poland
Website Url:
http://www.mabion.eu
Total Employee:
51+
Status:
Active
Contact:
+48 42 207 78 90
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Apache
Similar Organizations
BioCoS
BioCoS is a biotechnology company.
Biotools B&M Labs
Biotools B&M Labs S.A. is a Spanish biotechnology company
Edelweiss Connect
Edelweiss Connect is a biotechnology company.
Marealis AS
Marealis AS is a biotechnology company.
NeuroMax
NeuroMax is a Russian biotechnology company
VibioSphen
VibioSphen is a biotechnology company.
Virun
Virun specializes in formulating and manufacturing novel nutritional products.
Official Site Inspections
http://www.mabion.eu Semrush global rank: 2.14 M Semrush visits lastest month: 9.43 K
- Host name: cloudserver138927.home.pl
- IP address: 188.128.238.243
- Location: Poland
- Latitude: 52.2394
- Longitude: 21.0362
- Timezone: Europe/Warsaw
More informations about "Mabion S.A."
Home page - Mabion
As one would anticipate from an EU based CDMO, we guarantee the highest levels of production and analytics standards for your business. Additionally, our “can-do” approach to our clients’ needs offers solutions to unforeseen …See details»
Team - Mabion
Mabion is first of all people – creative, open and cooperative. The support we give each other during the realization of everyday tasks and the co-responsibility each of us takes for the success of our projects make it easier to achieve the goals …See details»
Home - Mabion
We are the first, most experienced biotechnology company in Poland and, as pioneers, we have laid the foundations of the life science sector in our country. Ambitious plans require solid …See details»
Environmental Protection - Mabion
Emissions management and organization’s carbon footprint monitoring, Climate change risk prevention and opportunity management, Effective waste management, Energy performance …See details»
Mabion S.A. | LinkedIn
Mabion S.A. is a Polish biopharmaceutical CDMO providing extensive drug development and biomanufacturing services to pharmaceutical and Biotech companies globally.See details»
Mabion - BIO International Convention | BIO
Mabion is a fully integrated CDMO located in central Europe and established in 2007 to develop and support the development of protein-based biotherapeutics, including monoclonal …See details»
Integrated Management System - Mabion
To maintain the highest standards of work, we have implemented and maintain at our main location an Integrated Management System (“IMS”) in the areas of environmental protection, …See details»
Mabion S.A. - Crunchbase Company Profile & Funding
Mabion S.A. is a biotechnology company. View contacts for Mabion S.A. to access new leads and connect with decision-makers. Mabion S.A. is the first Polish biotechnology company and the …See details»
Mabion | Pharma Contract Manufacturing
Mabion, a fully integrated CDMO located in central Europe, was established in 2007 to develop and support the development of protein-based biotherapeutics, including monoclonal …See details»
ESG - Mabion
The adopted ESG Strategy is based on three pillars, accompanied by strategic and operational goals that allow us to monitor the progress of its implementation. Our ESG Strategy is closely …See details»
ABOUT MABION - biosimilardevelopment.com
Mabion is a fully integrated CDMO located in central Europe and established in 2007 to develop and support the development of protein-based biotherapeutics, including monoclonal …See details»
Management and Supervisory Board - Mabion - old123.mabion.eu
Extensive expertise in the area of business scale development, an extensive list of completed strategic projects in the region of Central and Eastern Europe.See details»
Drug Substance Manufacturing - Mabion
Mabion offers clinical and commercial drug substance manufacturing of therapeutic proteins using mammalian and insect cell cultures, including biosimilars, innovative monoclonals, vaccine …See details»
Mabion | Scientist.com
Mabion provides antibody humanization, cell line development, and GMP stability studies. If your organization has a Scientist.com marketplace, you can log in here to order products and …See details»
Analytics - Mabion
Mabion offers a broad panel of analytical methods, including potency, purity, and sterility assessment to guarantee consistent quality throughout the entire process of biologic drug …See details»
Corporate governance at Mabion - Mabion
Information on the status of applied corporate governance recommendations and principles contained in the “Best Practices of WSE Listed Companies 2021” Corporate governance …See details»
Mabion presents ESG Strategy for 2024-2027
Mabion has adopted an ESG Strategy for 2024-2027 setting the Company's goals in the environmental, social and corporate governance areas.See details»
Press releases - Mabion
Sep 11, 2023 · Growing pipeline of submitted bids and another period of solid results and operating cash flow for Mabion in Q1 2024See details»
A synergy of excellence: Novavax-Mabion partnership during ...
Novavax was among several companies that took up the gauntlet and managed to introduce a vaccine (Nuvaxovid) in less than two years since the beginning of the pandemic. Starting in …See details»
Process Development - Mabion
At Mabion, we employ a data-driven approach to upstream development, starting with milliliter volumes to define optimal conditions for cell growth and protein expression, through scaling …See details»